Fulcrum Therapeutics, Inc. 8-K

Accession 0001193125-22-191340

Filing information

CIK: 0001680581
Report date: 2022-07-08
Filing date: 2022-07-11
Form: 8-K
Primary document: d338706d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.